|
Aug 5
|
InspireMD Reports Second Quarter 2025 Financial Results
|
|
Aug 4
|
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
|
|
Aug 3
|
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 60%, even after 11% gain this past week
|
|
Jul 31
|
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
|
|
Jul 31
|
InspireMD Announces Combined Financings of $58 Million
|
|
Jul 22
|
InspireMD to Announce Second Quarter 2025 Financial Results
|
|
Feb 13
|
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
|